Published in ISRN Inflamm on April 22, 2014
Point-of-care diagnosis of periodontitis using saliva: technically feasible but still a challenge. Front Cell Infect Microbiol (2015) 0.81
Salivary Antimicrobial Peptides in Early Detection of Periodontitis. Front Cell Infect Microbiol (2015) 0.76
Influence of Type 2 Diabetes on Prevalence of Key Periodontal Pathogens, Salivary Matrix Metalloproteinases, and Bone Remodeling Markers in Sudanese Adults with and without Chronic Periodontitis. Int J Dent (2016) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Points of control in inflammation. Nature (2002) 10.61
Periodontal diseases. Lancet (2005) 10.13
Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol (2010) 5.59
Dentists' attitudes toward chairside screening for medical conditions. J Am Dent Assoc (2010) 3.95
Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol (2000) 3.40
Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest (1976) 3.21
Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res (1998) 3.01
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol (2009) 3.01
The pathogenesis of human periodontitis: an introduction. Periodontol 2000 (1997) 2.94
Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum (2007) 2.90
Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc (2006) 2.80
Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med (2008) 2.63
The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res (2008) 2.53
Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48
IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol (1998) 2.45
Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A (2007) 2.39
Periodontitis and diabetes: a two-way relationship. Diabetologia (2011) 2.27
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol (2007) 2.22
Adult Dental Health Survey 2009: common oral health conditions and their impact on the population. Br Dent J (2012) 2.12
Host responses in periodontal diseases: current concepts. J Periodontol (1992) 2.12
Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res (1993) 2.12
Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol (2011) 2.11
The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 (1997) 2.10
Analytical epidemiology of periodontitis. J Clin Periodontol (2005) 2.10
Analysis of saliva for periodontal diagnosis--a review. J Clin Periodontol (2000) 2.04
Role of matrix metalloproteinases in human periodontal diseases. J Periodontol (1993) 1.98
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97
Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol (2010) 1.96
Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88
Dental plaque biofilms: communities, conflict and control. Periodontol 2000 (2011) 1.79
Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol (2009) 1.72
Disease progression: identification of high-risk groups and individuals for periodontitis. J Clin Periodontol (2005) 1.70
Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis. Periodontol 2000 (2010) 1.69
Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 (2009) 1.66
How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol (2011) 1.66
Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res (2007) 1.65
Definitions of periodontal disease in research. J Clin Periodontol (2008) 1.63
Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol Res (2007) 1.63
The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand (2007) 1.60
Patients' attitudes toward screening for medical conditions in a dental setting. J Public Health Dent (2011) 1.58
Effects of smoking cessation on the outcomes of non-surgical periodontal therapy: a systematic review and individual patient data meta-analysis. J Clin Periodontol (2013) 1.52
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol (1996) 1.52
Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 (1997) 1.51
Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl (2009) 1.51
Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res (2010) 1.45
Human saliva proteome and transcriptome. J Dent Res (2006) 1.43
Unification of the "burst" and "linear" theories of periodontal disease progression: a multilevel manifestation of the same phenomenon. J Dent Res (2003) 1.43
New concepts of destructive periodontal disease. J Clin Periodontol (1984) 1.43
Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci (2007) 1.39
Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res (1994) 1.38
Salivary diagnosis: more than a lick and a promise. J Am Dent Assoc (1993) 1.38
Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res (2011) 1.37
Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol (1986) 1.36
Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol (2009) 1.35
The clinical value of salivary biomarkers for periodontal disease. Periodontol 2000 (2009) 1.33
Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol (2013) 1.31
Liquid chromatography-mass spectrometry-based quantitative proteomics. J Biol Chem (2011) 1.30
Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol (2007) 1.29
Screening of periodontitis with salivary enzyme tests. J Oral Sci (2006) 1.26
Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000 (2010) 1.26
Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci (2007) 1.26
Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics (2007) 1.25
Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol (2013) 1.23
Gingival crevice fluid flow. Periodontol 2000 (2003) 1.23
Oral hygiene in the prevention of periodontal diseases: the evidence. Periodontol 2000 (2011) 1.23
Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol (2011) 1.22
Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res (2005) 1.21
Global periodontal disease epidemiology. Periodontol 2000 (2012) 1.21
Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol (2003) 1.21
Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res (1990) 1.21
Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res (2005) 1.19
The potential role of dentists in identifying patients' risk of experiencing coronary heart disease events. J Am Dent Assoc (2005) 1.19
Salivary biomarkers of oral health: a cross-sectional study. J Clin Periodontol (2012) 1.19
Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol (2010) 1.17
Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res (2009) 1.15
Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J Periodontol (2009) 1.15
Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol (2010) 1.12
Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J Periodontal Res (2009) 1.12
Lipid peroxidation and antioxidant activity in saliva of periodontitis patients: effect of smoking and periodontal treatment. Clin Oral Investig (2008) 1.12
Salivary enzyme levels after scaling and interleukin-1 genotypes in Japanese patients with chronic periodontitis. J Periodontol (2007) 1.10
Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res (1990) 1.10
Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol (2009) 1.08
Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000 (2005) 1.07
Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000 (2007) 1.06
Immunological differences and similarities between chronic periodontitis and aggressive periodontitis. Periodontol 2000 (2010) 1.05
Biomarkers of periodontitis in oral fluids. J Oral Sci (2008) 1.05
Inflammatory biomarkers in saliva: assessing the strength of association of diabetes mellitus and periodontal status with the oral inflammatory burden. J Clin Periodontol (2012) 1.03
Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol (2012) 1.03
Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases? Clin Chem Lab Med (2006) 1.02
Association between passive smoking and salivary markers related to periodontitis. J Clin Periodontol (2006) 1.02
The role of IL-6 in the pathogenesis of periodontal disease. Oral Dis (1998) 1.02
A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Periodontol (2013) 1.02
Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis. J Clin Periodontol (2009) 1.02
Salivaomics. J Am Dent Assoc (2012) 1.01
Salivary biomarkers: relationship between oxidative stress and alveolar bone loss in chronic periodontitis. Acta Odontol Scand (2013) 1.01
Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch Oral Biol (1995) 1.01
Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics (2010) 1.01
Modulation of clinical expression of plaque-induced gingivitis. II. Identification of "high-responder" and "low-responder" subjects. J Clin Periodontol (2004) 1.01
Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res (1998) 1.00